RAC 2.92% $1.94 race oncology ltd

Ann: Breakthrough Zantrene Heart Protection Discovery, page-112

  1. 517 Posts.
    lightbulb Created with Sketch. 144
    In light of all the above, it seems feasible that RAC might become a licensing company. We have something that all BP companies want (or soon will). Why should we be swallowed up by (or 'marry') just one BP when we can more or less dictate terms to the whole lot?
    Last edited by virtuozi: 22/11/21
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.